All Stories

  1. Antenatal Prediction of Shoulder Dystocia and Birth Trauma Using Routine Maternal and Ultrasound Variables: Retrospective Cohort Study
  2. Development of an Integrated Deep Learning Approach for Detecting Fetal Brain Abnormalities in Routine Second Trimester Ultrasound Scan: A Multicenter Study
  3. Development of a Deep Learning Algorithm for Posterior Fossa Abnormality Recognition on First-Trimester US Screening Scans: AIRFRAME Study Part 1
  4. Author Reply
  5. Authors' reply
  6. Author Reply
  7. Author response
  8. Effect of Targeted Aspirin Administration Based on First Trimester Combined Screening for Preeclampsia on Preterm Birth: An Interrupted Time Series Analysis
  9. Cardiac dysfunction during adverse maternal outcomes in hypertensive disorders of pregnancy
  10. ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction
  11. Impact of hypertensive disorders on disease progression in pregnancies affected by early‐onset fetal growth restriction
  12. Ambulatory foetal ECG monitoring in low and high-risk pregnancies (AMBER2): a prospective cohort study protocol
  13. Delphi consensus definition of fetal growth restriction after 8 years: implementation and future directions
  14. Translatable in‐vivo investigation of effects of progressive hypoxia in pregnancy on fetal cardiac structure and function in sheep
  15. Assessing the Clinical Effectiveness of the TRUFFLE Monitoring Protocol for Early-Onset Fetal Growth Restriction: a Retrospective Cohort Study.
  16. Foetal Cardiac Function in Early Labour and Intrapartum Outcomes: A Prospective Observational Study
  17. Predicting Adverse Perinatal Outcomes in Dichorionic Twin Pregnancies: A Multicentre Cohort Study
  18. The Impact of Dating Twin Pregnancy by the Larger, Smaller or Mean Twin Crown‐Rump Length: A Retrospective Cohort Study
  19. CARDIAC DYSFUNCTION DURING ADVERSE MATERNAL OUTCOMES IN HYPERTENSIVE DISORDERS OF PREGNANCY
  20. Comparison of glycosylated fibronectin versus soluble fms-like tyrosine kinase/placental growth factor ratio testing for the assessment of pre-eclampsia: protocol for a multicentre diagnostic test accuracy study
  21. Point‐of‐Care Tests for Preeclampsia: Systematic Review and Meta‐Analysis of Diagnostic Test Accuracy Studies
  22. Postnatal outcome of fetal cortical malformations: systematic review
  23. Cardiovascular Adaptation in Fetal Growth Restriction: A Longitudinal Study From Fetuses at Term to the First Year of Life
  24. TWIN PREGNANCY OUTCOMES WHEN DATING BY THE LARGER, SMALLER OR MEAN TWIN CROWN-RUMP LENGTH: A COHORT STUDY
  25. Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes
  26. Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation
  27. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction
  28. Angiogenic markers and maternal echocardiographic indices in women with hypertensive disorders of pregnancy
  29. Routine first‐trimester pre‐eclampsia screening and maternal left ventricular geometry
  30. Postpartum cardiovascular function in patients with hypertensive disorders of pregnancy: a longitudinal study
  31. Pre-eclampsia and Cardiovascular Disease: From Pregnancy to Postpartum
  32. Correlation of short‐term variation derived from novel ambulatory fetal electrocardiography monitor with computerized cardiotocography
  33. Phase‐rectified signal averaging: correlation between two monitors and relationship with short‐term variation of fetal heart rate
  34. The significance of meeting Dawes–Redman criteria in computerised antenatal fetal heart rate assessment
  35. Is mid‐gestational uterine artery Doppler still useful in a setting with routine first‐trimester pre‐eclampsia screening? A cohort study
  36. Pan-Genomic Regulation of Gene Expression in Normal and Pathological Human Placentas
  37. Peripartum and Long-Term Maternal Cardiovascular Health After Preeclampsia
  38. Authors' reply re: The dangers of biological essentialism in addressing birth equity
  39. Routine first‐trimester pre‐eclampsia screening and risk of preterm birth
  40. Author’s reply re: The Dangers of Biological Essentialism in Addressing Birth Equity: letter to the editor
  41. Placental dysfunction screening and perinatal loss
  42. Pregnant women having a small for gestational age fetus present lower cardiac contractility
  43. Maternal echocardiographic changes in twin pregnancies with and without pre‐eclampsia
  44. Understanding maternal postnatal blood pressure changes following hypertensive disorders in pregnancy: protocol for a prospective cohort study
  45. Reducing health inequality in Black, Asian and other minority ethnic pregnant women: impact of first trimester combined screening for placental dysfunction on perinatal mortality
  46. Peripartum echocardiographic changes in women with hypertensive disorders of pregnancy
  47. Myocardial Mechanics in Hypertensive Disorders of Pregnancy: a Systematic Review and Meta-Analysis
  48. SARS-CoV-2 related myocardial injury might explain the predisposition to preeclampsia with maternal SARS-CoV-2 infection
  49. The placenta and preeclampsia: villain or victim?
  50. Effect of routine first‐trimester combined screening for pre‐eclampsia on small‐for‐gestational‐age birth: secondary interrupted time series analysis
  51. Re: ASPRE trial: risk factors for development of preterm pre‐eclampsia despite aspirin prophylaxis
  52. Placenta Accreta Spectrum Disorders and Cesarean Scar Pregnancy Screening: Are we Asking the Right Questions?
  53. Urgent neonatal balloon atrial septostomy in simple transposition of the great arteries: predictive value of fetal cardiac parameters
  54. Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
  55. The association between a shared placenta and pregnancy outcome in triplet pregnancies
  56. Time to reconsider elective Cesarean birth
  57. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low‐lying placenta and previous uterine surgery
  58. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre‐eclampsia: a systematic review and meta‐analysis
  59. Reduction in twin stillbirth following implementation of NICE guidance
  60. Performance of Antenatal Diagnostic Criteria of Twin-Anemia-Polycythemia Sequence
  61. Non‐immune fetal hydrops: etiology and outcome according to gestational age at diagnosis
  62. The Association Between Hypertension in Pregnancy and Preterm Birth with Fetal Growth Restriction in Singleton and Twin Pregnancy: Use of Twin Versus Singleton Charts
  63. Maternal Cardiac Dysfunction Precedes Development of Preeclampsia
  64. Implementation of routine first trimester combined screening for pre‐eclampsia: a clinical effectiveness study
  65. Post-Laser Twin Anemia Polycythemia Sequence: Diagnosis, Management, and Outcome in an International Cohort of 164 Cases
  66. Selective Fetal Growth Restriction in Dichorionic Twin Pregnancies: Diagnosis, Natural History, and Perinatal Outcome
  67. Speckle Tracking Echocardiography: New Ways of Translational Approaches in Preeclampsia to Detect Cardiovascular Dysfunction
  68. Evidence for uteroplacental malperfusion in fetuses with major congenital heart defects
  69. Role of prenatal magnetic resonance imaging in fetuses with isolated mild or moderate ventriculomegaly in the era of neurosonography: a multicenter study
  70. Diagnosis of fetal abnormalities using exome sequencing: translating research into practice
  71. Cesarean Scar Pregnancy Registry: an international research platform
  72. Ductus venosus Doppler waveform pattern in fetuses with early growth restriction
  73. The impact of gestational diabetes on maternal cardiac adaptation to pregnancy
  74. Maternal cardiovascular function and risk of intrapartum fetal compromise in women undergoing induction of labor: a pilot study
  75. Maternal arterial stiffness in hypertensive pregnancies with and without a small‐for‐gestational‐age neonate
  76. Consensus diagnostic criteria and monitoring of twin anemia polycythemia sequence: a Delphi procedure
  77. Influence of maternal characteristics and gestational age on hemodynamic indices: NICOM device‐specific reference ranges
  78. Cardiac maladaptation in obese pregnant women at term
  79. Early and late selective fetal growth restriction in monochorionic diamniotic twin pregnancies: natural history and diagnostic criteria
  80. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small‐for‐gestational‐age fetus?
  81. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function
  82. Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study
  83. Weight discordance and perinatal mortality in monoamniotic twin pregnancies: analysis of the MONOMONO, NorSTAMP and STORK multiple pregnancy cohorts
  84. Comparative analysis of the 2‐year outcomes in the GRIT and TRUFFLE trials
  85. Left ventricular torsional mechanics in term fetuses and neonates
  86. Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics
  87. Long‐term neuroimaging and neurological outcome of fetal spina bifida aperta after postnatal surgical repair
  88. Prediction of adverse pregnancy outcome in monochorionic diamniotic twin pregnancy complicated by selective fetal growth restriction
  89. Risk of operative delivery for intrapartum fetal compromise in small-for-gestational-age fetuses at term: external validation of the IRIS algorithm
  90. Perinatal outcome of monochorionic twin pregnancy complicated by selective fetal growth restriction according to management: systematic review and meta‐analysis
  91. Selective fetal growth restriction in monochorionic twin pregnancy: a dilemma for clinicians and a challenge for researchers
  92. Longitudinal change in the cerebroplacental ratio and the risk of stillbirth
  93. Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta‐analysis
  94. Perinatal changes in fetal cardiac geometry and function in gestational diabetic pregnancies at term
  95. Preeclampsia and the cardiovascular system: An update
  96. Placental thickness in the lower uterine segment and invasive placentation: Will the promise live up?
  97. Cardiac output measurements during high-risk caesarean section using electrical bioreactance or arterial wave form analysis: an assessment of agreement
  98. Lower uterine segment placental thickness in women with abnormally invasive placenta
  99. Book: Genetics for obstetricians and gynaecologists
  100. Sensitivity of first-trimester ultrasound in the detection of congenital anomalies in twin pregnancies: population study and systematic review
  101. Mid-pregnancy fetal growth, uteroplacental Doppler indices and maternal demographic characteristics: role in prediction of stillbirth
  102. Mid-pregnancy fetal biometry, uterine artery Doppler indices and maternal demographic characteristics: role in prediction of small-for-gestational-age birth
  103. Recurrence of hypertensive disorders of pregnancy: an individual patient data metaanalysis
  104. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial
  105. Re: Maternal obesity and excess of fetal growth in pre-eclampsia
  106. Accuracy of Predicting Fetal Loss in Twin Pregnancies Using Gestational Age-Dependent Weight Discordance Cut-Offs: Analysis of the STORK Multiple Pregnancy Cohort
  107. Neonatal Acid-Base Status in Term Fetuses: Mathematical Models Investigating Cerebroplacental Ratio and Birth Weight
  108. Perioperative management and outcomes of aortic surgery during pregnancy
  109. Poor neonatal acid-base status in term fetuses with low cerebroplacental ratio
  110. Ushering in a new dawn in obstetrics and gynecology: the industry of cell-free DNA testing
  111. Fetal growth reference ranges in twin pregnancy: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  112. Cardiovascular Implications in Preeclampsia
  113. Reversible De Novo Left Ventricular Trabeculations in Pregnant Women
  114. Crown–rump length discordance and adverse perinatal outcome in twin pregnancies: systematic review and meta‐analysis
  115. Association between reduced fetal movements at term and first trimester markers of impaired placental development
  116. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia
  117. Neurodevelopmental outcome in isolated mild fetal ventriculomegaly: systematic review and meta-analysis
  118. Ultrasound estimation of birth weight in twin pregnancy: comparison of biometry algorithms in the STORK multiple pregnancy cohort
  119. Widening of the femoral proximal diaphysis-metaphysis angle in fetuses with achondroplasia
  120. Fetal and placental vascular tumors: persistent fetal hyperdynamic status predisposes to poorer long-term neurodevelopmental outcome
  121. Association between reduced fetal movements at term and abnormal uterine artery Doppler indices
  122. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women
  123. Outcome of first-trimester fetal abdominal cysts: cohort study and review of the literature
  124. Changes in fetal Doppler indices as a marker of failure to reach growth potential at term
  125. Multiple pregnancy: Preface
  126. Prenatal prediction of need for ventriculoperitoneal shunt in open spina bifida
  127. Twin pregnancy chorionicity determination in a tertiary care setting
  128. Brain abnormalities and neurodevelopmental delay in congenital heart disease: systematic review and meta-analysis
  129. Second-trimester discordance and adverse perinatal outcome in twins: the STORK multiple pregnancy cohort
  130. Comment on “First trimester uterine artery Doppler velocimetry in the prediction of birth weight in a low-risk population”
  131. Biparietal diameter at 11 to 13 weeks' gestation in fetuses with holoprosencephaly
  132. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial
  133. “Assisted” Reshaping of the Fetal Heart?
  134. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
  135. Biparietal diameter at 11–13 weeks' gestation in fetuses with open spina bifida
  136. Value of adding second-trimester uterine artery Doppler to patient characteristics in identification of nulliparous women at increased risk for pre-eclampsia: an individual patient data meta-analysis
  137. Embryonic growth discordance and early fetal loss: the STORK multiple pregnancy cohort and systematic review
  138. Association between first‐trimester maternal serum pregnancy‐associated plasma protein‐A and obstetric complications
  139. Role of cerebroplacental ratio for fetal assessment in prolonged pregnancy
  140. Intrafetal laser treatment for twin reversed arterial perfusion sequence: cohort study and meta-analysis
  141. Crown-rump length discordance and adverse perinatal outcome in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  142. Early fetal loss in monochorionic and dichorionic twin pregnancies: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  143. Weight discordance and perinatal mortality in twins: analysis of the Southwest Thames Obstetric Research Collaborative (STORK) multiple pregnancy cohort
  144. Does antenatal ultrasound labeling predict birth order in twin pregnancies?
  145. Trophoblast-Induced Changes in C-X-C Motif Chemokine 10 Expression Contribute to Vascular Smooth Muscle Cell Dedifferentiation During Spiral Artery Remodeling
  146. Comparison of Wavelet Transform and Time-Domain Analysis of Second Trimester Uterine Artery Doppler Waveforms in Screening for Pre-Eclampsia
  147. Cardiac structure and function in normal pregnancy
  148. Mid‐gestational maternal cardiovascular profile in preterm and term pre‐eclampsia: a prospective study
  149. Elective birth at 37 weeks of gestation versus standard care for women with an uncomplicated twin pregnancy at term: the Twins Timing of Birth Randomised Trial
  150. Counseling in fetal medicine: agenesis of the corpus callosum
  151. The diagnostic and therapeutic role of ultrasound in obstetrics
  152. Severe Myocardial Impairment and Chamber Dysfunction in Preterm Preeclampsia
  153. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality
  154. Prediction of Preeclampsia by Combining Serum Histidine-Rich Glycoprotein and Uterine Artery Doppler
  155. Neurodevelopmental delay in small babies at term: a systematic review
  156. Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth Restriction
  157. Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance
  158. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies
  159. Corrections
  160. Relationship of first‐trimester uterine artery Doppler to late stillbirth
  161. Prospective risk of late stillbirth in monochorionic twins: a regional cohort study
  162. LEFT VENTRICULAR HYPERTRABECULATION IN AFRO-CARIBBEAN INDIVIDUALS: AN INHERITED CARDIOMYOPATHY OR A PHYSIOLOGICAL RESPONSE TO INCREASED CARDIAC PRELOAD
  163. A perfusion confusion?
  164. Prediction of selective fetal growth restriction and twin-to-twin transfusion syndrome in monochorionic twins
  165. Role of Second-Trimester Uterine Artery Doppler in Assessing Stillbirth Risk
  166. Screening for pre-eclampsia by using changes in uterine artery Doppler indices with advancing gestation
  167. Is first‐trimester crown–rump length associated with birthweight?
  168. Maternal cardiac function in preeclampsia
  169. Pregnancy Outcome of Monochorionic Twins: Does Amnionicity Matter?
  170. Antibiotic prophylaxis before amniocentesis
  171. The evidence base for miscarriage diagnosis: better late than never
  172. Preeclampsia Is Associated With Persistent Postpartum Cardiovascular Impairment
  173. Antenatal care for twin and triplet pregnancies: summary of NICE guidance
  174. Elevated glucocorticoid metabolism in placental tissue from first trimester pregnancies at increased risk of pre-eclampsia
  175. Systematic labeling of twin pregnancies on ultrasound
  176. Early prediction and prevention of pre-eclampsia
  177. Fetal hemoglobin and α1-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia
  178. First‐trimester ultrasound determination of chorionicity in twin pregnancy
  179. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices
  180. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies?
  181. Prevalence of maternal cardiac defects in women with high‐resistance uterine artery Doppler indices
  182. Prenatal diagnosis of non‐immune hydrops fetalis: what do we tell the parents?
  183. Maternal Cardiac Dysfunction and Remodeling in Women With Preeclampsia at Term
  184. Second‐trimester assessment of gestational age in twins: validation of singleton biometry charts
  185. Early pregnancy growth and pregnancy outcome in twin pregnancies
  186. Late termination of pregnancy and foetal reduction for foetal anomaly
  187. Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia
  188. First-trimester ultrasound dating of twin pregnancy: are singleton charts reliable?
  189. Prenatal ultrasound in the prediction of bowel obstruction in infants with gastroschisis
  190. Prenatal findings and differential diagnosis of scimitar syndrome and pulmonary sequestration
  191. Sensitivity of higher, lower and mean second-trimester uterine artery Doppler resistance indices in screening for pre-eclampsia
  192. Giant placental chorioangioma: natural history and pregnancy outcome
  193. Cord entanglement and perinatal outcome in monoamniotic twin pregnancies
  194. The diagnostic and therapeutic role of ultrasound in obstetrics
  195. Guidelines for the management of postterm pregnancy
  196. Raised Maternal Serum Cystatin C: An Early Pregnancy Marker for Preeclampsia
  197. Relationship of intertwin crown-rump length discrepancy to chorionicity, fetal demise and birth-weight discordance
  198. First trimester PTX3 levels in women who subsequently develop preeclampsia and fetal growth restriction
  199. First‐trimester uterine artery Doppler indices in the prediction of small‐for‐gestational age pregnancy and intrauterine growth restriction
  200. Association of Uterine Artery Doppler Resistance Index and Birth Weight: Effect of Customized Birth Weight Standards
  201. First trimester uterine artery Doppler in women with previous pre‐eclampsia
  202. Congenital vascular malformations: A series of five prenatally diagnosed cases
  203. First-trimester uterine artery Doppler indices in term and preterm pre-eclampsia
  204. Outcome of Fetuses With Antenatally Diagnosed Short Femur
  205. Predictors of necrotizing enterocolitis in preterm growth-restricted neonates
  206. Outcome of fetuses with antenatally diagnosed short femur
  207. First‐trimester uterine artery resistance and maternal serum concentration of asymmetric dimethylarginine
  208. Defective endovascular trophoblast invasion in the first trimester is associated with increased maternal serum ischemia-modified albumin
  209. The prediction of intra-partum fetal compromise in prolonged pregnancy
  210. Ultrasound assessment of cervical length in prolonged pregnancy: prediction of spontaneous onset of labor and successful vaginal delivery
  211. Authors response to: Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  212. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses
  213. Outcome of antenatally diagnosed abdominal wall defects
  214. First trimester maternal serum ischaemia-modified albumin: a marker of hypoxia-ischaemia-driven early trophoblast development
  215. Effect of heparin and fractionated heparin on trophoblast invasion
  216. Increased Apoptosis in First Trimester Extravillous Trophoblasts from Pregnancies at Higher Risk of Developing Preeclampsia
  217. Influence of parity on fetal mortality in prolonged pregnancy
  218. Severe twin-twin transfusion syndrome: outcome after fetoscopic laser ablation of the placental vascular equator
  219. Problem Based Obstetric Ultrasound
  220. MRI of the foetal brain
  221. Outcome of prenatally diagnosed agenesis of the corpus callosum
  222. Posterior fossa malformation in fetuses: a report of 56 further cases and a review of the literature
  223. The role of ultrasound in obstetrics
  224. Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction
  225. First‐trimester uterine artery Doppler and spontaneous preterm delivery
  226. Maternal and neonatal outcome after failed ventouse delivery: Comparison of forceps versus cesarean section
  227. Prenatal diagnosis of segmental spinal dysgenesis
  228. Maternal cardiac function in early pregnancies with high uterine artery resistance
  229. Uterine artery Doppler velocimetry at 11–14 weeks in singleton pregnancies conceived by assisted reproductive technology
  230. Fetal surgical interventions
  231. Influence of parity on first trimester endovascular trophoblast invasion
  232. Do early pregnancy ultrasound measurements correlate with fetal nuchal translucency at 11–14 weeks?
  233. First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations
  234. Effect of first-trimester serum from pregnant women with high-resistance uterine artery Doppler resistance on extravillous trophoblast invasion
  235. Effect of inter-twin delivery interval on neonatal haemoglobin concentration
  236. Effect of low dose heparin, unfractionated heparin and aspirin on trophoblast invasion
  237. Computerized fetal heart rate analysis (CCTG) for prediction of acidemia in fetal growth restriction (IUGR)
  238. Effect of serum from women with abnormal uterine artery Doppler resistance on extravillous trophoblast invasion in the first trimester
  239. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results
  240. A newly described thoracic vascular malformation in fetuses with Down syndrome
  241. Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations
  242. First-Trimester Ductus Venosus, Nasal Bones, and Down Syndrome in a High-Risk Population
  243. The sensitivity of antenatal ultrasound for predicting renal tract surgery in early childhood
  244. Fetal congenital cardiac diverticulum with pericardial effusion: two cases with different presentations in the first trimester of pregnancy
  245. Natural history and outcome of prenatally diagnosed cystic hygroma
  246. Recent advances in the management of placenta previa
  247. Second‐trimester uterine artery Doppler and spontaneous preterm delivery
  248. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies
  249. What prenatal diagnosis should be offered in multiple pregnancy?
  250. The Longitudinal Variation in Uterine Artery Blood Flow Pattern in Relation to Birth Weight
  251. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices
  252. Viability in early-onset IUGR: is it time to reconsider intervention thresholds?
  253. Effect of parity on second‐trimester uterine artery Doppler flow velocity and waveforms
  254. Ultrasound-guided interstitial laser therapy for the treatment of placental chorioangioma
  255. Pre-natal diagnosis: structural anomalies
  256. First‐trimester uterine artery blood flow and birth weight
  257. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia
  258. Association between increased nuchal translucency and second trimester cardiac echogenic foci*1
  259. The role of oxytocin in parturition
  260. A newly recognized autosomal recessive syndrome with abnormal vertebral ossification, rib abnormalities, and nephrogenic rests
  261. Nuchal translucency thickness measurement: repeatability using a virtual ultrasound scanner
  262. Improving the effectiveness of routine prenatal screening for major congenital heart defects
  263. Prospective risk of stillbirth in multiple-gestation pregnancies: a population-based analysis
  264. Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening
  265. Comparison of feticide carried out by cordocentesis versus cardiac puncture
  266. Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population
  267. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  268. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus
  269. Sensitivity and accuracy of routine antenatal ultrasound screening for isolated facial clefts
  270. Routine ultrasound for the prenatal diagnosis of congenital diaphragmatic hernia: the ‘isms’
  271. Fetal medicine: a liquid frontier
  272. Uterine artery resistance and anxiety in the second trimester of pregnancy
  273. The human ductus venosus between 13 and 17 weeks of gestation: histological and morphometric studies
  274. Reproducibility and repeatability of transabdominal uterine artery Doppler velocimetry between 10 and 14 weeks of gestation
  275. The anatomy of the umbilical, portal and hepatic venous systems in the human fetus at 14-19 weeks of gestation
  276. Significance of chromosome 22q11 analysis after detection of an increased first-trimester nuchal translucency
  277. The role of ultrasound in the expectant management of early pregnancy loss
  278. Fetal anemia as a consequence of hemorrhage into an ovarian cyst
  279. Improved early prediction of pre-eclampsia by combining second-trimester maternal serum inhibin-A and uterine artery Doppler
  280. Intraobserver and interobserver variability of transabdominal Doppler velocimetry measurements of the fetal ductus venosus between 10 and 14 weeks of gestation
  281. Role of ultrasound in obstetrics
  282. Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound
  283. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects
  284. Increased nuchal translucency and normal karyotype: coping with uncertainty
  285. Antenatal diagnosis of fetal intra‐abdominal umbilical vein dilatation
  286. Sono-endoscopic delineation of the placental vascular equator prior to selective fetoscopic laser ablation in twin-to-twin transfusion syndrome
  287. Twin-to-twin transfusion syndrome - debates on the etiology, natural history and management
  288. Coping with winter bed crises
  289. Effectiveness of prenatal chromosomal analysis using multicolour fluorescent in situ hybridisation
  290. First trimester screening for fetal abnormalities
  291. First trimester nuchal translucency: effective routine screening for Down's syndrome.
  292. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
  293. First‐trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: a happy union?
  294. Influence of ethnic origin on nuchal translucency screening for Down's syndrome
  295. TRANSFER OF NUCLEATED MATERNAL CELLS INTO FETAL CIRCULATION DURING THE SECOND TRIMESTER OF PREGNANCY
  296. A nude mouse xenograft model to investigate slow cycling edidermal stem cells
  297. Relationship between fetal nuchal translucency thickness and second trimester maternal serum biochemistry
  298. Racial equity of screening for trisomy 21: comparison of nuchal translucency and maternal serum biochemistry
  299. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
  300. Nuchal translucency: a marker for the antenatal diagnosis of aortic coarctation
  301. Maternal platelet size as a marker for fetal trisomies 18 and 13
  302. Neutrophil and monocyte β2-integrin expression in trisomic fetuses
  303. Blood transferrin receptor expression in chromosomally abnormal fetuses
  304. Neutrophil and monocyte β2-integrin expression in maternal and fetal blood
  305. Labor: An immunologically beneficial process for the neonate
  306. Fetal immunodeficiency: A consequence of placental insufficiency
  307. Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood
  308. Predicting the severity of rhesus alloimmunization: monocyte-mediated chemiluminescence versus maternal anti-D antibody estimation
  309. Subpopulations of CD34‐positive haemopoietic progenitors in fetal blood
  310. Umbilical cord blood erythroblast count as an index of intrauterine hypoxia.
  311. Abnormal immunological development in fetuses with trisomy 18
  312. Fetal Blood Mononuclear Cell Division in Normal and Pathological Pregnancies
  313. Maternal Peripheral Blood Lymphocyte Subpopulations in Normal and Pathological Pregnancies
  314. Fetal plasma erythropoietin concentration in red blood cell‐isoimmunized pregnancies
  315. Fetal plasma interferon gamma concentration in normal pregnancy
  316. Abnormal fetal immunological development in Down's syndrome
  317. Fetal B Lymphocyte Subpopulations in Normal Pregnancies
  318. Management of the third stage of labour in women at low risk of postpartum haemorrhage
  319. Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies
  320. Erythroblastosis in birth asphyxia
  321. Fetal and Maternal Erythropoietin Levels in Normal Pregnancy
  322. Cordocentesis in the investigation of fetal erythropoiesis
  323. Erythroblastosis and reticulocytosis in anemic fetuses
  324. Antenatal care for women with pre-existing medical, obstetric or mental health conditions